Showing results (1611-1620 of 1,710) with videos related to

Sort By:
Pageof 171
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Breast Cancer Research and Treatment|October 1, 2011
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerFrederik Marmé, Wiebke Werft, Anne Walter, et al.
The Lancet. Oncology|December 14, 2017
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyCarsten Denkert, Gunter von Minckwitz, Silvia Darb-Esfahani, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 15, 2025
Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice AnalysisAlessandro Brunelli, Alessio Mariolo, Clemens Aigner, et al.
NPJ Breast Cancer|June 25, 2019
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancerBruno V Sinn, Chunxiao Fu, Rosanna Lau, et al.
Translational Lung Cancer Research|May 20, 2021
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter studyLuka Brcic, Thomas Klikovits, Zsolt Megyesfalvi, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnosticsFelix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
The Lancet. Child & Adolescent Health|May 15, 2020
The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trialWilliam O Tarnow-Mordi, Mohamed E Abdel-Latif, Andrew Martin, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Pageof 171